AXQ Capital LP Invests $447,000 in The Clorox Company (NYSE:CLX)

AXQ Capital LP bought a new stake in The Clorox Company (NYSE:CLX - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 2,754 shares of the company's stock, valued at approximately $447,000.

Several other institutional investors have also recently bought and sold shares of CLX. Ilex Capital Partners UK LLP increased its position in Clorox by 512.7% during the 3rd quarter. Ilex Capital Partners UK LLP now owns 542,110 shares of the company's stock worth $88,315,000 after purchasing an additional 453,624 shares in the last quarter. Amundi boosted its stake in shares of Clorox by 42.6% during the fourth quarter. Amundi now owns 1,032,283 shares of the company's stock valued at $165,816,000 after purchasing an additional 308,234 shares in the last quarter. Assenagon Asset Management S.A. grew its holdings in shares of Clorox by 302.0% during the fourth quarter. Assenagon Asset Management S.A. now owns 353,367 shares of the company's stock worth $57,390,000 after purchasing an additional 265,455 shares during the last quarter. State Street Corp increased its stake in shares of Clorox by 3.1% in the third quarter. State Street Corp now owns 8,182,109 shares of the company's stock valued at $1,332,947,000 after buying an additional 245,525 shares during the period. Finally, Raymond James Financial Inc. bought a new position in Clorox in the 4th quarter valued at approximately $37,935,000. Institutional investors and hedge funds own 78.53% of the company's stock.

Clorox Stock Up 1.9 %

NYSE CLX traded up $2.72 on Thursday, hitting $145.70. 1,282,431 shares of the company were exchanged, compared to its average volume of 1,213,119. The company has a current ratio of 0.94, a quick ratio of 0.60 and a debt-to-equity ratio of 20.52. The company has a market cap of $17.95 billion, a PE ratio of 39.81, a PEG ratio of 2.62 and a beta of 0.45. The stock has a fifty day moving average of $151.92 and a 200-day moving average of $159.31. The Clorox Company has a 12 month low of $127.60 and a 12 month high of $171.37.

Remove Ads

Clorox (NYSE:CLX - Get Free Report) last released its quarterly earnings data on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same quarter in the previous year, the firm posted $2.16 EPS. As a group, analysts forecast that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, May 9th. Stockholders of record on Wednesday, April 23rd will be given a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.35%. The ex-dividend date is Wednesday, April 23rd. Clorox's payout ratio is 133.33%.

Analyst Ratings Changes

A number of research firms have weighed in on CLX. Evercore ISI boosted their target price on shares of Clorox from $145.00 to $155.00 in a report on Tuesday, February 4th. StockNews.com downgraded Clorox from a "buy" rating to a "hold" rating in a report on Sunday, January 5th. Barclays cut their target price on Clorox from $140.00 to $139.00 and set an "underweight" rating on the stock in a report on Thursday. JPMorgan Chase & Co. increased their price target on Clorox from $171.00 to $173.00 and gave the company a "neutral" rating in a research note on Tuesday, February 4th. Finally, DA Davidson cut their price objective on Clorox from $171.00 to $169.00 and set a "neutral" rating on the stock in a research note on Wednesday, February 5th. Three research analysts have rated the stock with a sell rating, ten have issued a hold rating and one has given a buy rating to the company's stock. According to MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus price target of $159.50.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.